News

miR-122 is a liver-expressed microRNA that has been shown to be a critical endogenous ‘host factor’ for the replication of HCV and anti-miRs targeting miR-122 have been shown

LSO’s global Phase 3 trial of Aptocine in metastatic colorectal cancer (MCRC) has reached target enrollment of 450 patients at 52 sites. The controlled, randomised MCRC trial is

The drug discovery expertise includes fragment screening, structural biology and protein crystallography, to discover and profile novel compounds against additional antibacterial targets selected by Cubist. Evotec and Cubist

As per the terms of the settlement, Ethex will plead guilty to criminal charges, and will be required to pay a fine and restitution of $25.8m. Ethex also

In addition to a license agreement and Restraint Agreement, Derma Sciences and Comvita also entered into several other related agreements, including a collaborative research and development agreement, a

HPLC is a seperation technique that utilizes different types of stationary phase, a pump generating a gradient of two different solvents, a steel enforced column and an apparatus

The new drug application 22-299 provides for the use of Nevirapine tablets for oral suspension 50mg in combination with other antiretrovirals and its indicated for the treatment of

The lawsuit claimed that the company advocated biliary stents in the treatment of obstructions in peripheral blood vessels. The companies that make them are barred from promoting or

The US patent is expected to expire on October 30, 2022 and, in addition, the US PTO has granted a patent term adjustment of 300 days, leading to